Stevanato Group S.p.A. has grown revenue 6.4% a year over three years and 12% a year over five, with earnings per share compounding at −1.9%. Revenue growth, 3-year annual rate: +6.4% (Medical Instruments & Supplies median +10%). Revenue growth, 5-year rate: +12%, growth has slowed since the five-year average. Earnings per share, 3-year rate: −1.9%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 7, FY2019 to FY2025, as filed.

STVNStevanato Group S.p.A.

HealthcareUSD

$22.42

$13.3852 weeks$27.51

Is it growing?

Is STVN growing?

Stevanato Group S.p.A. has grown revenue 6.4% a year over three years and 12% a year over five, with earnings per share compounding at −1.9%.

+6.4%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +10% · steady growth, ahead of inflation · compounded from fiscal years as filed

Revenue growth, 5-year rate: +12%
Revenue growth, 5-year rate · +6.4% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: −1.9%
Earnings per share, 3-year rate · revenue +6.4% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed